Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
815.76
768.67
817.18
779.07
791.06
810.01
1,061.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
815.76
768.67
817.18
779.07
791.06
810.01
1,061.19
Raw Material Cost
640.16
616.91
660.00
616.97
647.77
664.18
926.01
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.23
1.24
1.37
1.27
1.65
0.92
2.14
Selling and Distribution Expenses
108.61
103.23
134.64
106.72
102.89
105.10
118.93
Other Expenses
2.04
2.25
3.01
2.50
2.08
1.86
4.02
Total Expenditure (Excl Depreciation)
770.36
743.91
826.13
749.97
773.14
788.78
1,087.29
Operating Profit (PBDIT) excl Other Income
45.4
24.8
-8.9
29.1
17.9
21.200000000000003
-26.099999999999998
Other Income
3.53
12.55
20.73
7.86
5.52
14.03
58.77
Operating Profit (PBDIT)
78.36
68.51
29.65
75.44
60.07
72.98
-16.64
Interest
1.23
1.24
1.37
1.27
1.65
0.92
2.14
Exceptional Items
-7.76
2.79
-10.29
-1.83
13.08
-1.07
-3.48
Gross Profit (PBDT)
175.61
151.76
157.19
162.10
143.28
145.83
135.18
Depreciation
35.88
35.88
44.17
44.17
42.21
42.21
49.28
Profit Before Tax
33.49
34.18
-26.18
28.17
29.29
28.78
-71.54
Tax
8.34
5.28
-0.99
4.32
5.57
5.01
1.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
22.38
28.00
-14.54
20.12
25.35
22.98
-30.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
22.38
28.00
-14.54
20.12
25.35
22.98
-30.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.96
1.64
-8.98
4.28
-0.11
2.19
-23.24
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26.34
29.64
-23.53
24.40
25.24
25.17
-54.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,765.90
3,805.78
3,777.72
3,792.36
3,772.43
3,814.02
3,791.09
Earnings per share (EPS)
0.04
0.04
-0.02
0.03
0.04
0.04
-0.05
Diluted Earnings per share
0.04
0.04
-0.02
0.03
0.04
0.04
-0.05
Operating Profit Margin (Excl OI)
4.77%
2.61%
-4.31%
3.01%
1.56%
2.07%
-11.75%
Gross Profit Margin
8.5%
9.11%
2.2%
9.29%
9.04%
8.76%
-2.1%
PAT Margin
2.74%
3.64%
-1.78%
2.58%
3.2%
2.84%
-2.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 6.13% vs -5.93% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -11.15% vs 225.96% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 33.57% vs 529.21% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -14.29% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Jinling Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
815.76
0
815.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
815.76
0
815.76
Raw Material Cost
640.16
0
640.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.23
0
1.23
Selling and Distribution Expenses
108.61
0
108.61
Other Expenses
2.04
0.00
2.04
Total Expenditure (Excl Depreciation)
770.36
0
770.36
Operating Profit (PBDIT) excl Other Income
45.40
0.00
45.40
Other Income
3.53
0
3.53
Operating Profit (PBDIT)
78.36
0
78.36
Interest
1.23
0
1.23
Exceptional Items
-7.76
0
-7.76
Gross Profit (PBDT)
175.61
0
175.61
Depreciation
35.88
0
35.88
Profit Before Tax
33.49
0
33.49
Tax
8.34
0
8.34
Provisions and contingencies
0
0
0.00
Profit After Tax
22.38
0
22.38
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
22.38
0
22.38
Share in Profit of Associates
0
0
0.00
Minority Interest
3.96
0
3.96
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.34
0
26.34
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,765.90
0
3,765.90
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
4.77%
0%
0.00
4.77%
Gross Profit Margin
8.50%
0%
0.00
8.50%
PAT Margin
2.74%
0%
0.00
2.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 81.58 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 6.13% vs -5.93% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3.12% vs 3.49% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.63 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -11.15% vs 225.96% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 4.37% vs 176.92% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.48 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 33.57% vs 529.21% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 37.00% vs 3.41% in Jun 2025
Quarterly - Interest
Interest 0.12 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -14.29% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -29.41% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.77%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
